170 related articles for article (PubMed ID: 11364776)
1. Protease inhibitors and anticonvulsants.
Brooks J; Daily J; Schwamm L
AIDS Clin Care; 1997 Nov; 9(11):87, 90. PubMed ID: 11364776
[TBL] [Abstract][Full Text] [Related]
2. Methadone and antiretroviral medications, part II.
Gourevitch MN; Friedland GH
AIDS Clin Care; 1999 May; 11(5):37, 43, 45-6. PubMed ID: 11367102
[TBL] [Abstract][Full Text] [Related]
3. Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease.
Merry C; Mulcahy F; Barry M; Gibbons S; Back D
AIDS; 1997 Feb; 11(2):268-9. PubMed ID: 9030388
[No Abstract] [Full Text] [Related]
4. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
5. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.
Wilkins E
J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268
[No Abstract] [Full Text] [Related]
6. Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir.
Bates DE; Herman RJ
Ann Pharmacother; 2006 Jun; 40(6):1190-5. PubMed ID: 16720703
[TBL] [Abstract][Full Text] [Related]
7. HIV treatment options.
Smith D
AIDS Treat News; 1998 May; (No 294):4-5. PubMed ID: 11365404
[TBL] [Abstract][Full Text] [Related]
8. Superior virological efficacy of ritonavir-boosted protease inhibitor regimens compared to single protease inhibitor therapy.
Lichterfeld M; Wöhrmann A; Schmeisser N; Fätkenheuer G; Salzberger B; Wyen C; Schmitz K; Sauerbruch T; Rockstroh JK
Eur J Med Res; 2003 Feb; 8(2):56-60. PubMed ID: 12626282
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of antiretroviral drugs.
Hoetelmans RM
Antivir Ther; 1999; 4 Suppl 3():29-41. PubMed ID: 16021869
[TBL] [Abstract][Full Text] [Related]
10. [HIV-1 protease inhibitors. Why, when, and how?].
Gatell JM
Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):393-4. PubMed ID: 9887623
[No Abstract] [Full Text] [Related]
11. Protease inhibitors at a glance...
Notes Undergr; 1998-1999 Winter; (No 38):suppl 1-4. PubMed ID: 11366198
[TBL] [Abstract][Full Text] [Related]
12. [Optimisation of epilepsy monotherapy (clinico-pharmacological study)].
Gromov SA; Khorshev SK
Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(7):31-5. PubMed ID: 9511212
[TBL] [Abstract][Full Text] [Related]
13. Carbamazepine toxicity after starting combination antiretroviral therapy including ritonavir and efavirenz.
Burman W; Orr L
AIDS; 2000 Dec; 14(17):2793-4. PubMed ID: 11125901
[No Abstract] [Full Text] [Related]
14. Simplifying drug regimens.
HIV Hotline; 1998 Mar; 8(1):11. PubMed ID: 11365353
[TBL] [Abstract][Full Text] [Related]
15. A generalized seizure following initiation of nelfinavir in a patient with human immunodeficiency virus type 1 infection, suspected due to interaction between nelfinavir and phenytoin.
Honda M; Yasuoka A; Aoki M; Oka S
Intern Med; 1999 Mar; 38(3):302-3. PubMed ID: 10337948
[TBL] [Abstract][Full Text] [Related]
16. What they say about protease inhibitors.
Posit Aware; 1999; 10(1):38-43. PubMed ID: 11366522
[TBL] [Abstract][Full Text] [Related]
17. Predictors of virologic response to ritonavir-boosted protease inhibitors.
Marcelin AG; Flandre P; Peytavin G; Calvez V
AIDS Rev; 2005; 7(4):225-32. PubMed ID: 16425962
[TBL] [Abstract][Full Text] [Related]
18. Salvage with Nelfinavir doesn't always work.
TreatmentUpdate; 1998 Aug; 10(6):2-3. PubMed ID: 11365702
[TBL] [Abstract][Full Text] [Related]
19. Ritonavir-boosted protease inhibitor monotherapy for the treatment of HIV-1 infection.
Sahali S; Chaix ML; Delfraissy JF; Ghosn J
AIDS Rev; 2008; 10(1):4-14. PubMed ID: 18385776
[TBL] [Abstract][Full Text] [Related]
20. Strategies for protease inhibitor failure.
Proj Inf Perspect; 1997 Nov; (23):4-5. PubMed ID: 11365379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
